Northern Nigerian Breaking News

WHO to resume trial of hydroxychloroquine on COVID-19

9

The World Health Organisation (WHO) will resume its trial of hydroxychloroquine for the treatment of coronavirus (COVID-19) patients, its Director-General, Dr Tedros Ghebreyesus, says.

Ghebreyesus, who stated this on the official twitter account of the UN health agency, said the hydroxychloroquine section of WHO’s Solidarity Trial can resume after being paused temporarily on May 25.

The trial’s Data Safety and Monitoring Committee had halted the study as a precaution in response to safety concerns raised by an observational study published in the Lancet.

Ghebreyesus said the Data Safety Monitoring Board’s review had been completed.

“Last week, the Executive Group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug.

elsamad new

Read Also:Federal University Dutse Begins Clinical Trial Of Plant-Based COVID-19 Medicine(Opens in a new browser tab)

First 100 days Infographics

“This decision was taken as a precaution while the safety data were reviewed. The Data Safety and Monitoring Committee of the Solidarity Trial has been reviewing the data.

“On the basis of available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.

“The Executive Group received this recommendation and endorsed the continuation of all arms of the Solidarity Trial, including hydroxychloroquine.

“The Executive Group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,’’ he said.

The WHO director-general said the Data Safety and Monitoring Committee would continue to closely monitor the safety of all therapeutics being tested in the Solidarity Trial.

“So far, more than 3,500 patients have been recruited in 35 countries.

“WHO is committed to accelerating the development of effective therapeutics, vaccines and diagnostics as part of our commitment to serving the world with science, solutions and solidarity,’’ he said.

Meanwhile, Nigeria on May 27 declared that it would continue with hydroxychloroquine clinical trials on COVID-19 patients.

Prof. Mojisola Adeyeye, the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC), said the country would continue with the drug.

She said this would be in spite of the initial warning by WHO to discontinue using it.

“I do not know the data they’re looking at, whether it’s from the Caucasian population or from the African population.

“If the data they’re looking at, and the reason for suspending the trials, is from the Caucasian population, then it may be justified.

“But I don’t think we have data from the African population yet, because our genetic make-up is different.

“If medical doctors, research scientists, pharmacists and herbal experts work together, we should conclude the clinical trial in three to four months.

“The narrative may change afterwards. But for now, we believe in hydroxychloroquine,” she said. (NAN)

9 Comments
  1. cvv fullz 1000$ says

    959459 828404Glad to be 1 of several visitants on this amazing web site : D. 704835

  2. lbgxkg says
  3. ทางเข้า maxbet says

    497527 306447Thank you for the auspicious writeup. It in reality was a amusement account it. Appear complicated to far delivered agreeable from you! However, how can we keep in touch? 260295

  4. Damita says

    This is my first time visit at here and i am genuinely pleassant to read everthing at single place.

  5. Promise says

    I’m amazed, I must say. Seldom do I encounter a blog that’s both educative and engaging, and let me tell you, you’ve hit the nail on the head. The problem is something that too few folks are speaking intelligently about. Now i’m very happy that I came across this during my search for something regarding this.

  6. RobertHob says

    I gave [url=https://www.cornbreadhemp.com/products/full-spectrum-cbd-gummies ]cbd and thc gummies[/url] a prove with a view the cardinal habits, and I’m amazed! They tasted great and provided a sense of calmness and relaxation. My importance melted away, and I slept better too. These gummies are a game-changer an eye to me, and I extremely put forward them to anyone seeking appropriate stress relief and well-advised sleep.

  7. RobertHob says

    I gave https://www.cornbreadhemp.com/products/cbd-sleep-gummies a try with a view the primary previously, and I’m amazed! They tasted smashing and provided a intelligibility of calmness and relaxation. My stress melted away, and I slept outstrip too. These gummies are a game-changer for me, and I extremely put forward them to anyone seeking appropriate pain alleviation and improved sleep.

  8. thc gummies says

    I gave cbd gummies a whack at for the treatment of the cardinal time, and I’m amazed! They tasted smashing and provided a sanity of calmness and relaxation. My stress melted away, and I slept better too. These gummies are a game-changer for me, and I highly commend them to anyone seeking appropriate pain relief and better sleep.

  9. Robertjab says

    CBD, or cannabidiol, has been a feign changer payable to the truly that me. https://mjcbdd.com/collections/delta-8-gummies I’ve struggled with observe in bring back years and secure tried sundry disparate medications, but nothing has worked as properly as CBD. It helps me to to all appearances sang-froid and over-tolerant without any side effects. I also espy that it helps with take for and hurt management. I’ve tried sundry brands, but I’ve inaugurate that the ones that are lab tested and work hand in glove a quip on a genuine repute are the most effective. Overall, I exceptionally recommend CBD representing anyone who struggles with apprehension, be in the nation of okay issues, or inveterate pain.

Leave A Reply

Your email address will not be published.